Le Lézard
Classified in: Health
Subject: PDT

Nystrom & Associates to Open a New Clinic in Hudson


HUDSON, Wis., April 21, 2021 /PRNewswire/ -- Nystrom & Associates, Ltd., one of the Nation's largest behavioral health and substance use disorder providers, announces the opening of its new clinic in Hudson at 2501 Hanley Rd., Ste. 201, Hudson, WI 54016. The clinic is scheduled to open May 17, 2021.

Nystrom's new outpatient clinic will serve all ages and will offer Hudson: Psychiatry/Medication Management and Therapy.

"We're very excited and honored to be expanding these very important services into the Hudson community. The need for high quality behavioral health and substance use addiction services persists, in Hudson and throughout the nation, and we're humbled to create better access and even greater convenience through our expansion. We have a phenomenal team of clinical providers and management who came together to make this possible," Peter Nystrom, Chief Commercial Officer of Nystrom & Associates noted.

Founded in 1991, Nystrom & Associates will have 30 clinic locations throughout Minnesota, Wisconsin, and Iowa and is comprised of professional care providers from the fields of psychiatry, psychology, clinical social work, marriage and family therapy, substance use disorder, and nursing who are committed to helping individuals and families that are experiencing personal, emotional, marital, or psychological problems.

About Nystrom & Associates
Nystrom & Associates is a group of professional care providers from the fields of psychiatry, psychology, clinical social work, marriage and family therapy, substance use disorder, and nursing. Nystrom employs 1,200+ people throughout 30 clinic locations with a commitment to create access to care help individuals and families struggling with personal, emotional, marital, or psychological problems. Nystrom also offers tele-behavioral health and addiction services: www.nystromcounseling.com

To schedule, call 1-844-NYSTROM.

 

SOURCE Nystrom & Associates


These press releases may also interest you

at 21:45
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

at 21:30
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...

at 19:30
Willow Biosciences Inc. ("Willow" or the "Company") , a leading biotechnology...

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...



News published on and distributed by: